← All companies
HALOZYME THERAPEUTICS, INC.
HALO - CIK 0001159036
Market cap$8.36 B
Rank#1040
SEC filings1,481
The table below shows HALOZYME THERAPEUTICS, INC.'s balance sheet line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $133.82M | $115.85M | $118.37M | $234.19M | $118.72M | $147.70M |
| Short-term investments | - | - | - | - | - | - |
| Receivables | $426.27M | $288.20M | - | $231.07M | $90.97M | $97.73M |
| Inventory | $176.47M | $141.86M | $127.60M | $100.12M | $53.91M | $60.75M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.